Showing results (41-50 of 109) with videos related to
Sort By:
Pageof 11
Pharmaceutics|June 27, 2024
Constitutional DNA Polymorphisms Associated with the Plasma Imatinib Concentration in Chronic Myeloid Leukemia PatientsHeriberto Bruzzoni-Giovanelli, Habib Zouali, Mourad Sahbatou, et al.Blood|December 9, 2008
Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantationAnne Janin, Hideyuki Murata, Christophe Leboeuf, et al.Blood|January 8, 2005
Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 studyVahid Asnafi, Agnes Buzyn, Xavier Thomas, et al.The American Journal of Surgical Pathology|September 24, 2021
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected PatientsJulien Calvani, Laurence Gérard, Jehane Fadlallah, et al.Blood|July 28, 2005
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotypeNicolas Boissel, Aline Renneville, Valeria Biggio, et al.Journal of Clinical Medicine|November 26, 2022
Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL)Jeannig Berrou, Mélanie Dupont, Hanane Djamai, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemiaNicolas Boissel, Delphine Rea, Vannary Tieng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie PédiatriqueMarie-Cécile Le Deley, Thierry Leblanc, Akthar Shamsaldin, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2013
Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategyEmilie Sbidian, Maxime Battistella, Jérome Legoff, et al.Oncotarget|July 14, 2020
Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinibAlexis Genthon, Franck Emmanuel Nicolini, Françoise Huguet, et al.Pageof 11